TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Drugs AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
226,707
|
200,521
|
174,541 |
Financial expenses |
9
|
50
|
81 |
Earnings before taxes |
10,011
|
-1,985
|
-2,492 |
EBITDA |
9,471
|
-2,621
|
-3,223 |
Total assets |
114,305
|
92,950
|
107,936 |
Current assets |
113,565
|
91,339
|
105,301 |
Current liabilities |
45,298
|
30,683
|
36,170 |
Equity capital |
65,757
|
59,049
|
67,108 |
- share capital |
13,433
|
13,365
|
14,543 |
Employees (average) |
25
|
26
![]() |
26 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
57.5%
|
63.5%
|
62.2% |
Turnover per employee |
9,068
|
7,712
|
6,713 |
Profit as a percentage of turnover |
4.4%
|
-1.0%
|
-1.4% |
Return on assets (ROA) |
8.8%
|
-2.1%
|
-2.2% |
Current ratio |
250.7%
|
297.7%
|
291.1% |
Return on equity (ROE) |
15.2%
|
-3.4%
|
-3.7% |
Change turnover |
25,154
|
40,117
|
-33,441 |
Change turnover % |
12%
|
25%
|
-16% |
Chg. No. of employees |
-1
|
0
|
-1 |
Chg. No. of employees % |
-4%
|
0%
|
-4% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.